Skip to content
Delayed ~15 min

PBH PRESTIGE CONSUMER HEALTHCARE

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Thu 4 Feb 2027 · estimated

What 5 analyst firms say about PRESTIGE CONSUMER HEALTHCARE: their latest ratings, price targets and how far the stock is from them. How it works

42.98 USD−1.34 (−3.02%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+42.5%to the avg target 61.25 USD+18.27 USD
Buy 2 · Hold 3 · Sell 0

5 rated views · 5 analyst/firm records · 5 firms

Latest report29 Oct 2026avg report date 24 Jun
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8035
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8029

Recent analyst activity · last 90 days

Our tracked history has 2 reports on PBH from 1 analyst firm in the last 90 days (5 firms in the past year).

Comparing each firm's latest target with its previous one: 1 left it unchanged.

Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Canaccord GenuitySusan K AndersonBuy14 May 202672.00 USD
JefferiesKeith DevasHold15 May 202655.00 USD
OppenheimerUnnamed analystHold14 May 202665.00 USD · 7 May 2026
William BlairJon R AndersenBuy13 May 2026—
Data feed RESEARCHResearch TeamHold29 Oct 202653.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 05:54 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.